Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ankyrin repeat domain 26 pseudogene 3 (ANKRD26P3) is a genomic sequence with high homology to the functional ANKRD26 gene but lacks protein-coding capacity due to accumulated mutations or truncations. Pseudogenes like ANKRD26P3 do not translate into functional proteins and are not direct drug targets. Some pseudogenes can produce regulatory non-coding RNAs that might influence expression of related genes, but no such role is specifically established for ANKRD26P3 in the literature[3][4][6][7].
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ankyrin repeat domain 26 pseudogene 3 (ANKRD26P3).